1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [3ee5416a-797b-498d-b8f0-3ce46bcb97bc] => Array
        (
            [runtime-id] => 3ee5416a-797b-498d-b8f0-3ce46bcb97bc
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [dfd16b02-10de-4958-ade9-b44ce12d1e44] => Array
                        (
                            [runtime-id] => dfd16b02-10de-4958-ade9-b44ce12d1e44
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;7a3961c2e4438e05417a6618a8cc47465b60cd39
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [3ee5416a-797b-498d-b8f0-3ce46bcb97bc] => Array
        (
            [runtime-id] => 3ee5416a-797b-498d-b8f0-3ce46bcb97bc
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [dfd16b02-10de-4958-ade9-b44ce12d1e44] => Array
                        (
                            [runtime-id] => dfd16b02-10de-4958-ade9-b44ce12d1e44
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;7a3961c2e4438e05417a6618a8cc47465b60cd39
                )

        )

)

Table 3:

Clinical outcomes*

Combined (n = 16)IV rtPA (n = 13)P Value
Successful recanalization (TIMI 2,3)14 (88%)
Improvement of NIHSS score (24 hours)11 ± 4.85 ± 4.3.0007
Favorable outcome (mRS 0,1) (90 days)10 (63%)2 (15%).022
Symptomatic ICH (36 hours)01 (8%)
Asymptomatic ICH (36 hours)1 (6%)0
Mortality (90 days)1 (6%)0
  • Note:—IV indicates intravenous; rtPA, recombinant tissue plasminogen activator; TIMI, Thrombolysis in Myocardial Infarction grade; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; ICH, intracerebral hemorrhage.

  • * Data expressed as n (%) or mean ± SD.